Business Description
![Guardant Health Inc Guardant Health Inc logo](https://static.gurufocus.com/logos/0C0000BIF0.png?14)
Guardant Health Inc
NAICS : 621511
SIC : 8071
ISIN : US40131M1099
Description
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.84 | |||||
Equity-to-Asset | 0.04 | |||||
Debt-to-Equity | 19.73 | |||||
Debt-to-EBITDA | -3.25 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.19 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.6 | |||||
3-Year EBITDA Growth Rate | -18.8 | |||||
3-Year EPS without NRI Growth Rate | -18.1 | |||||
3-Year FCF Growth Rate | -24 | |||||
3-Year Book Growth Rate | -53.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 16.94 | |||||
Future 3-5Y Total Revenue Growth Rate | 20.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.37 | |||||
9-Day RSI | 57.64 | |||||
14-Day RSI | 58.39 | |||||
6-1 Month Momentum % | 30.33 | |||||
12-1 Month Momentum % | -24.01 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.95 | |||||
Quick Ratio | 5.66 | |||||
Cash Ratio | 5.13 | |||||
Days Inventory | 94.27 | |||||
Days Sales Outstanding | 52.7 | |||||
Days Payable | 95.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 0.42 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.37 | |||||
Operating Margin % | -87.85 | |||||
Net Margin % | -76.34 | |||||
FCF Margin % | -49.81 | |||||
ROE % | -327.6 | |||||
ROA % | -26.67 | |||||
ROIC % | -98.51 | |||||
ROC (Joel Greenblatt) % | -146.84 | |||||
ROCE % | -30.17 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.22 | |||||
PB Ratio | 58.93 | |||||
Price-to-Tangible-Book | 70.21 | |||||
EV-to-EBIT | -9.02 | |||||
EV-to-Forward-EBIT | -10.18 | |||||
EV-to-EBITDA | -9.96 | |||||
EV-to-Forward-EBITDA | -12.89 | |||||
EV-to-Revenue | 6.83 | |||||
EV-to-Forward-Revenue | 6.06 | |||||
EV-to-FCF | -13.71 | |||||
Earnings Yield (Greenblatt) % | -11.09 | |||||
FCF Yield % | -7.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guardant Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 603.725 | ||
EPS (TTM) ($) | -3.92 | ||
Beta | 1.37 | ||
Volatility % | 68.17 | ||
14-Day RSI | 58.39 | ||
14-Day ATR ($) | 1.495671 | ||
20-Day SMA ($) | 30.1825 | ||
12-1 Month Momentum % | -24.01 | ||
52-Week Range ($) | 15.81 - 41.06 | ||
Shares Outstanding (Mil) | 122.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guardant Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guardant Health Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Guardant Health Inc Frequently Asked Questions
What is Guardant Health Inc(GH)'s stock price today?
The current price of GH is $33.02. The 52 week high of GH is $41.06 and 52 week low is $15.81.
When is next earnings date of Guardant Health Inc(GH)?
The next earnings date of Guardant Health Inc(GH) is 2024-08-02 Est..
Does Guardant Health Inc(GH) pay dividends? If so, how much?
Guardant Health Inc(GH) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |